MedWorld Advisors 8/12/26 MedWorld Advisors 8/12/26

What medtech SMEs can learn from the megadeals

Capability-building medtech acquisitions are more relevant to the market than headline-grabbing transformational ones. Read more in our column, MedTech Mindset, in Today’s Medical Developments Magazine.

MedWorld Advisors 7/31/26 MedWorld Advisors 7/31/26

Shrink to Grow: What the Top 30’s Great Reshaping Means for Exits

The most important takeaway from the 2026 MPO Top 30 report is not embedded in any one transaction but rather the pattern among the ranked firms.

Estelle Black 7/22/26 Estelle Black 7/22/26

Why Reshoring, State-Level Growth, and Tariffs are Reshaping Medtech M&A Value

The conversation at FMMC mirrored some of the discussions taking place in deal rooms this year.

MedWorld Advisors 6/29/26 MedWorld Advisors 6/29/26

AI across the Medtech lifecycle: From the bench to the balance sheet

Medtech companies must assess where artificial intelligence creates value at each stage of the product lifecycle.

MedWorld Advisors 6/16/26 MedWorld Advisors 6/16/26

ODT FORUM 2026 On Demand - Rewatch Dave Sheppard’s State of the Industry Speech

Watch Dave Sheppard give the 2026 ODT Forum State of the Industry. This session provides a comprehensive overview of the happenings within the orthopedic device manufacturing industry. Supply chain, M&A, and other related topics critical to both OEMs and their supply partners are covered.

MedWorld Advisors 6/9/26 MedWorld Advisors 6/9/26

The Value of AI in MedTech - from Start-Up to Operation Excellence to M&A Webinar: Rewatch Here!

Rewatch our webinar with Today’s Medical Developments as we explore the value impacts of AI in MedTech in 2026 for MedTech companies at all stages of growth – from start-up to scale-up including operational excellence through M&A Exit.

MedWorld Advisors 6/3/26 MedWorld Advisors 6/3/26

The Ongoing Transformation of the Orthopedic Industry

The $75 billion orthopedic market is growing, but pricing pressure throughout the supply chain is intensifying.

MedWorld Advisors 5/27/26 MedWorld Advisors 5/27/26

Examining Cross-Border M&A Deals in Medtech—An MPO Videobites

With the global environment for medical device manufacturing, cross-border deals are common and may provide for a unique definition for success.

MedWorld Advisors 5/26/26 MedWorld Advisors 5/26/26

Stryker breach makes medical device cybersecurity a boardroom issue

When connected medical devices meet state-sponsored hackers, the C-suite owns the outcome.

MedWorld Advisors 5/11/26 MedWorld Advisors 5/11/26

Building Intrinsic Value in Your Medtech Business: The Disciplines That Drive Premium Exits

Medtech executives or board members with an eye toward a future liquidity event should start building intrinsic value in their respective organizations now.

MedWorld Advisors 4/23/26 MedWorld Advisors 4/23/26

What's your company really worth in 2026's medtech M&A market?

Understand what drives value in today’s medtech M&A market, from multiples and EBITDA to buyer strategy and deal timing.

Daniel Sheppard 4/15/26 Daniel Sheppard 4/15/26

The AI Valuation Gap at Exit: Why Medtech Companies Should Not Ignore AI

The buyers who will set valuations are already asking AI-specific questions during initial conversations.

MedWorld Advisors 4/6/26 MedWorld Advisors 4/6/26

From the Big Easy to the Big Picture: Key AAOS 2026 Takeaways

The lasting impression from AAOS 2026 is that the orthopedic industry is not waiting for the future.

MedWorld Advisors 3/26/26 MedWorld Advisors 3/26/26

Performance, not promise: The real AI premium in medtech

Manufacturing-related AI can contribute to value because it improves performance in ways buyers can underwrite.

MedWorld Advisors 3/2/26 MedWorld Advisors 3/2/26

Tariffs and the MedTech Industry: Disruption, Realignment, and Strategic Consequences

C-suites are being forced to include tariff dynamics into their short-term and long-term strategies.

MedWorld Advisors 2/23/26 MedWorld Advisors 2/23/26

AI in medical technology manufacturing: Balancing automation and human expertise

Combining human expertise with AI creates safer, faster, and more innovative medtech solutions.

MedWorld Advisors 2/19/26 MedWorld Advisors 2/19/26

Why Procedural Optimization and Additive Manufacturing Will Define Orthopedics in 2026

For the industry’s CDMOs, the future winners will not be defined by capacity or cost alone, but by their ability to co-engineer procedures.

MedWorld Advisors 2/16/26 MedWorld Advisors 2/16/26

Medtech M&A: What 2025 revealed — and what 2026 may bring

In the first edition of 2026 of Today’s Medical Developments Magazine, MedWorld Advisors discusses how mergers and acquisitions will continue to play a strong role in shaping the next generation of MedTech industry innovation.

MedWorld Advisors 2/5/26 MedWorld Advisors 2/5/26

How Global Tariffs Are Influencing Medtech M&A Trends

MD+DI covers key points from MedWorld Advisors panel at MD&M West 2026.

MedWorld Advisors 2/3/26 MedWorld Advisors 2/3/26

What 2026 Will Demand from Medtech Leadership in M&A

Passivity will not be rewarded in 2026—strategic acquirers have returned to the market in force.

Contact us.